New Test for Human Metapneumovirus

The test is marketed by Focus Technologies (Herndon, VA, USA), which has licensed the rights to nucleic acid diagnostic testing technology for hMPV from ViroNovative, a spinoff from Erasmus University (Rotterdam, The Netherlands). New evidence implicates hMPV in repeat episodes of respiratory infection, with symptoms ranging from mild common cold-like symptoms in adults to severe bronchitis or bronchiolitis in young children with first-time infection.

"It is exciting to be able to provide diagnostic testing for an important new pathogen like hMPV,” said Charles C. Harwood, Jr., president and CEO of Focus Technologies. "Human metapneumovirus is generating a great amount of interest from scientists who are investigating the prevalence and clinical significance of this new virus.”




Related Links:
Focus Technologies